S.a. Sinaf - Net Worth and Insider Trading

S.a. Sinaf Net Worth

The estimated net worth of S.a. Sinaf is at least $0 dollars as of 2024-11-13. S.a. Sinaf is the 10% Owner of Regenerx Biopharmaceuticals Inc and owns about 0 shares of Regenerx Biopharmaceuticals Inc (RGRX) stock worth over $0. Details can be seen in S.a. Sinaf's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that S.a. Sinaf has not made any transactions after 2018-03-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of S.a. Sinaf

To

S.a. Sinaf Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, S.a. Sinaf owns 2 companies in total, including Regenerx Biopharmaceuticals Inc (RGRX) , and SciClone Pharmaceuticals Inc (SCLN) .

Click here to see the complete history of S.a. Sinaf’s form 4 insider trades.

Insider Ownership Summary of S.a. Sinaf

Ticker Comapny Transaction Date Type of Owner
RGRX Regenerx Biopharmaceuticals Inc 2018-03-13 10 percent owner
SCLN SciClone Pharmaceuticals Inc 2010-06-29 other: Member of 10% owner group

S.a. Sinaf Latest Holdings Summary

S.a. Sinaf currently owns a total of 1 stock. S.a. Sinaf owns 0 shares of Regenerx Biopharmaceuticals Inc (RGRX) as of March 13, 2018, with a value of $0.

Latest Holdings of S.a. Sinaf

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RGRX Regenerx Biopharmaceuticals Inc 2018-03-13 0 0.00 0

Holding Weightings of S.a. Sinaf


S.a. Sinaf Form 4 Trading Tracker

According to the SEC Form 4 filings, S.a. Sinaf has made a total of 0 transactions in Regenerx Biopharmaceuticals Inc (RGRX) over the past 5 years. The most-recent trade in Regenerx Biopharmaceuticals Inc is the sale of 115,848 shares on March 13, 2018, which brought S.a. Sinaf around $3 Million.

Insider Trading History of S.a. Sinaf

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

S.a. Sinaf Trading Performance

GuruFocus tracks the stock performance after each of S.a. Sinaf's buying transactions within different timeframes. To be detailed, the average return of stocks after 1 year bought by S.a. Sinaf is -30%. GuruFocus also compares S.a. Sinaf's trading performance to market benchmark return within the same time period. The performance of stocks bought by S.a. Sinaf within 1 year outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how S.a. Sinaf's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of S.a. Sinaf

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 10 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 7.31 LIMIT LIMIT LIMIT LIMIT LIMIT

S.a. Sinaf Ownership Network

Ownership Network List of S.a. Sinaf

No Data

Ownership Network Relation of S.a. Sinaf

Insider Network Chart

S.a. Sinaf Owned Company Details

What does Regenerx Biopharmaceuticals Inc do?

Who are the key executives at Regenerx Biopharmaceuticals Inc?

S.a. Sinaf is the 10 percent owner of Regenerx Biopharmaceuticals Inc. Other key executives at Regenerx Biopharmaceuticals Inc include other: Member of 10% owner group Aptafin S P A , 10 percent owner Spa Essetifin , and 10 percent owner Francesca Cavazza .

Regenerx Biopharmaceuticals Inc (RGRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Regenerx Biopharmaceuticals Inc (RGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Regenerx Biopharmaceuticals Inc (RGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Regenerx Biopharmaceuticals Inc (RGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Regenerx Biopharmaceuticals Inc Insider Transactions

No Available Data

S.a. Sinaf Mailing Address

Above is the net worth, insider trading, and ownership report for S.a. Sinaf. You might contact S.a. Sinaf via mailing address: 26 Boulevard Royal, Luxembourg N4 L-2449.